Reply to: Letter to Editor re: “Mechanochemical endovenous ablation of saphenous veins using the ClariVein: A systematic review” – MOCA data reporting needs to be tighter and standardized!
Restricted accessLetterFirst published online December, 2017
Reply to: Letter to Editor re: “Mechanochemical endovenous ablation of saphenous veins using the ClariVein: A systematic review” – MOCA data reporting needs to be tighter and standardized!
Saravana K and Tang TY. Letter to editor re: “Mechanochemical endovenous ablation of saphenous veins using the ClariVein: A systematic review” – MOCA data reporting needs to be tighter and standardized. Phlebology 2017; 32: 679–681.
2.
Witte ME, Zeebregts CJ, de Borst GJ, et al. Mechanochemical endovenous ablation of saphenous veins using the ClariVein: a systematic review. Phlebology. 2017; 32: 649–657.
3.
SlimKNiniEForestierDet al.Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg2003; 73: 712–716.
4.
WitteMEHolewijnSvan EekerenRRet al.Mid-term outcome of mechanochemical endovenous ablation for the treatment of great saphenous vein insufficiency. J Endovasc Ther2017; 24: 149–155.
5.
BoersmaDvan HaelstSTvan EekerenRRet al.Macroscopic and histologic analysis of vessel wall reaction after mechanochemical endovenous ablation using the ClariVein OC Device in an animal model. Eur J Vasc Endovasc Surg2017; 53: 290–298.
6.
LamYLToonderIMWittensCH. ClariVein mechano-chemical ablation, an interim analysis of a randomized controlled trial dose finding study. Phlebology2016; 31: 170–176.
